S. boulardii may support normal colonization of the gut microbiome with commensal (beneficial) species by competing against undesirable bacteria and yeast species.* S. boulardii may help support an environment that is more friendly to potentially detrimental microbes and unsupportive to potentially pathogenic microbes. It may promote re establishment of a healthy microbiome after the use of certain medications.* The cell wall of S. boulardii yeast may also have prebiotic properties by promoting the production of short chain fatty acids (SCFAs), which are key metabolites produced by the microbiota in the large intestine and the preferred fuel source of intestinal cells. These SCFAs have many important biochemical functions, which include promoting a healthy inflammatory response in the gut, gut barrier integrity, and mucosal cell immune function.* S. boulardii may promote immune function and gut health.*
LymeCore’s Saccharomyces Boulardii contains 500 mg (or 10 billion viable cells at the time of manufacture) of the nonpathogenic yeast Saccharomyces boulardii per serving. S. boulardii possesses probiotic activity that promotes microbial diversity and supports gastrointestinal health and immune function.* This strain does not require refrigeration and can survive passage through the harsh gastric environment, withstanding high acidity, bile, and heat. This strain has extensive research for its potential use in promoting gastrointestinal health.*
Take 2 capsules per day or as directed by your health-care practitioner.